CLINICAL_TRIALS
research
· 2026-04-08
Clinical Trial Update: Genetic Studies of Chronic Active Epstein-Barr Disease
Summary
This clinical trial update details genetic studies investigating Chronic Active Epstein-Barr virus infection, sponsored by NIAID, which is currently recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Chronic Active Epstein-Barr Virus | Status: RECRUITING